George Karavetsos, shareholder in the firm’s FDA & Biotechnology and White Collar, Compliance & Investigations practices, sat down with CNN Politics for an article, “Biden struggles to find a permanent FDA chief as agency nears approval of Covid-19 vaccine.”
Woodcock has long been a respected leader among many within the agency, and even as acting commissioner she still has the full force and power to guide the agency, said George Karavetsos, who had been the director of the FDA’s Office of Criminal Investigations and now provides strategic advice to FDA regulated companies.
Having been detailed to the White House to work on Covid-19 vaccines through Operation Warp Speed and also having been the director of the Center for Drug Research and Evaluation, Woodcock is uniquely well-qualified to lead on the vaccine issue, he said.
“I can’t think of anybody who would be better positioned to the be the tip of the spear for the vaccine,” Karavetsos said. “There has been no letup on the gas with her in an acting capacity.”